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by Boisguerin et al. [12], a library of peptides was synthe-PDZ Domains and Their Ligands
sized on a solid support. Upon completion of the peptide
sequence, the N termini were further modified such that
they could loop back and attach to the solid support
Protein interaction domains (PIDs) such as the SH2 via a thioether. The C termini were then liberated from
and SH3 domains are known to drive protein:protein the solid support, leaving the peptides attached only by
interactions by binding to linear peptides. Screens of the N termini. When an array of peptides corresponding
peptide arrays and combinatorial peptide libraries to the C termini of 6223 human proteins was screened
have been used to identify the peptide sequences rec- against two PDZ domains, several new cellular partners
ognized by a given PID. Two reports in this issue of for the PDZ domains were identified. In the publication
Chemistry & Biology describe a new method for the by Piserchio et al. [13], cyclization was used to rigidify
synthesis of these peptide arrays and illustrate the a portion of a PDZ domain’s peptide ligand so that it
utility of peptide ligands. bound 10-fold tighter to its target. The three-dimen-
sional structure of the peptide-PDZ domain complex
Many eukaryotic proteins lack catalytic activity and in- was solved by NMR spectroscopy, and the cyclic pep-
stead exist solely to organize supramolecular com- tide was shown to perturb the normal activity of its target
plexes. Evolutionary forces have assembled these “or- in vivo. Both of these publications and their significance
ganizer” proteins from PIDs such as the SH2, SH3, EH, are discussed in more detail below.
and WW domains. These domains typically bind short To understand the contributions of the first publica-
peptide sequences with mid- to low-micromolar dissoci- tion, it must be appreciated that phage-display vectors
ation constants. (An excellent review detailing the large for C-terminal display of combinatorial peptide libraries
list of PIDs can be found elsewhere [1].) A wide variety have not been available until recently [5, 6]. Conse-
of cellular processes, such as signal transduction, re- quently, to map the specificity of most PDZ domains,
ceptor-mediated endocytosis, formation of the cy- only synthetic combinatorial peptide libraries were ap-
toskeleton, and synapse organization, depend upon propriate. However, unbeknownst to many molecular
protein complexes that are held together with PIDs. biologists, solid-phase peptide synthesis occurs from
The specificity of PIDs can be mapped quickly by the C terminus to the N terminus. Consequently, the C
screening soluble or immobilized peptide libraries or by terminus of the peptide remains attached to the solid
selecting ligands from phage or RNA displayed combi- support at the completion of the synthesis. While leaving
natorial peptide libraries. Typically, the peptides recov- the peptides attached permits screening with antibodies
ered by affinity selection share a consensus sequence and many PIDs, this has been problematic for screening
that defines the ligand preferences of the domain in against PDZ domains that recognize C termini. Thus,
question. Because the selected peptides and natural synthetic peptides needed to be cleaved off the solid
proteins tend to interact with the same “hot spot” on support prior to assaying binding to PDZ domains. Only
the PID [2, 3], the peptide consensus can be used in a a few soluble combinatorial peptide libraries are readily
computer search to predict the in vivo partners of the available, and while they are useful in identifying the
domains. These predictions are then confirmed or dis- optimal ligand preferences of PDZ domains [7], they do
proved through a variety of cellular and biochemical not permit quantitative binding comparisons of different
techniques (e.g., synthesis and testing of peptides de- peptide sequences to the same PDZ domain. Using the
rived from actual proteins, coimmunoprecipitation or SPOT method for chemically synthesizing peptides on
pull-downs from cell lysates, yeast two-hybrid screen- cellulose membranes [8], Jens Schneider-Mergener and
ing, etc.). colleagues in Berlin invented one chemical method for
One PID of great interest is the PDZ domain [4]. This inverting peptides on a solid support [9]. They demon-
100-residue domain occurs 785 times in 436 human strated its usefulness by synthesizing a library of 7-mer
proteins (http://smart.embl-heidelberg.de/). Some PDZ peptides, corresponding to 3514 human proteins, with
domains have been shown to bind C-terminal peptide free C termini. Screening this library with the human
sequences, while others bind internal regions. Although protein 1-syntrophin yielded 38 PDZ binding peptides.
PDZ domains share a common three-dimensional struc- Their sequences correspond to several known 1-syn-
ture, they generally differ in their binding specificities. trophin-interacting proteins as well as many interesting
In this “proteomics era,” it is of great interest to learn candidates for in vivo interactions.
the specificity of PDZ domains, to discover their cellular The work of Rudolf Volkmer-Engert and colleagues in
partners, and to fashion inhibitors of their protein-pro- Berlin, as reported in this issue, has expanded the size
tein interactions. In this way, the functional importance of the C-terminal library and modified the chemistry in-
of particular PDZ domains can be revealed. volved in SPOT synthesis [12]. A library of 6223 C termini
In this issue of Chemistry & Biology, two publications (11-mers) from human proteins was synthesized on cel-
utilize peptide ligands of PDZ domains to define their lulose membranes. Eight synthetic steps, in addition to
molecular recognition properties and to generate an an- the condensation of the Fmoc-protected amino acids,
tagonist [12, 13]. Coincidently, both laboratories used were involved in generating the inverted peptides. In
brief, the synthetic protocol began by attaching a mer-peptide cyclization in their approach. In the publication
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captopropionyl cysteine (side-chain protected) to the respectively. NMR spectroscopy of the complex formed
between the cyclic peptide and the PDZ domain re-N-modified cellulose amino-hydroxypropyl ether mem-
brane. The C-terminal amino acid of the desired peptide vealed that the peptide binds in the groove between
the 2 strand and 2 helix. Similar binding has beenwas then attached to the mercaptopropionyl group. Fol-
lowing the condensation of the next ten amino acids, the reported for the C termini of natural protein ligands. The
side chains of Lys3 and Glu1 can be seen to interactcompleted peptides were all coupled to Fmoc--alanine
pentafluorophenyl ester, Fmoc deprotected, and elon- with several residues in the 2 and 3 strands and the
lactam-containing ring projects perpendicular to the 2gated with bromoacetic acid 2,4-dinitrophenyl ester.
Selective deprotection of the cysteine side chain then strand (Protein Data Bank ID code 1RGR).
If the cyclic peptide specifically binds to the thirdallowed cyclization via thioether formation with the bro-
moacetic acid moiety. When the ester bond adjacent to PDZ domain of PSD-95, then it should antagonize its
interactions with other proteins. The authors tested thethe first amino acid is cleaved, the peptide becomes
inverted (i.e., it is now anchored to the membrane through effect of the peptide on the interaction between PSD-
95 and the GluR6 subunit of the kainite receptor. Humanits N-terminal amino acid). After optimizing the peptide
synthesis, positive hits against the 1-syntrophin PDZ do- embryonic kidney cells (HEK293) were transfected with
plasmids expressing GluR6 and PSD-95, and after 24main provided a 20-fold increase in signal strength com-
pared to the same peptides in the original library of hr the cyclic peptide and a linear peptide were trans-
duced into the cells with Sigma Chemical’s BioPORTERSchneider-Mergener. All of the strong binders from the
Schneider-Mergener library were also positive in the reagent. As monitored by coimmunoprecipitation exper-
iments, the cyclic peptide was 5-fold more effectivescreen of the Volker-Engert library. This correlation
served to validate the new synthetic approach. In addi- in disrupting the GluR6:PSD-95 interaction than a 15-
mer peptide corresponding to the C terminus of GluR6.tion, the new library revealed many positives that were
not tested originally. Furthermore, the cyclic peptide was successful in pre-
venting the clustering of the kainite receptor in cotrans-When the Volkmer-Engert library was screened
against the PDZ domain of human Erbin, a protein identi- fected cells, as monitored by immunofluorescence
staining. Compared to the linear peptide, the transducedfied by yeast two-hybrid screening to bind to the C
terminus of the receptor tyrosine kinase ErbB2, 40 cyclic peptide was effective over much longer periods
of time (18 hr versus 5 hr), suggesting that the cyclicstrong binders (Kd values from 8 to 110 M) were identi-
fied. Four of the most interesting hits (two potassium peptide is resistant to enzymatic degradation.
In conclusion, the “tool kit” for protein biochemistschannels, plasma membrane Ca2 ATPase, and the
breakpoint cluster region protein [BCR]) were selected interested in PDZ domains has become larger with the
two approaches introduced by the two publications infor further analysis. Amino acid substitutions of the
C-terminal sequences demonstrated that these four this month’s issue. Spotted arrays of peptide ligands
can be rapidly screened and generate hypothetical inter-peptides bound to the PDZ domain using a canonical
recognition sequence. Furthermore, the BCR protein acting partners to follow up experimentally. Once a pep-
tide ligand has been identified, it can be used to predictcould be successfully immunoprecipitated with Erbin
from lysates of cultured cells. This work demonstrates in vivo binding partners, concurrently synthesized in a
cyclic form, and used as an antagonist. Thus, by a com-that these arrays of C termini will have great value in
defining the specificity of the large collection of human bination of both approaches, the cellular role of PDZ
domain-containing proteins can be explored more ex-PDZ domains. A similar “proteome peptide scanning”
approach has been published recently, in which the peditiously in the future.
specificity of numerous SH3 domains was also defined
with SPOT synthesized arrays of yeast and human pro-
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